Vδ2 T cell subsets, defined by PD-1 and TIM-3 expression, present varied cytokine responses in acute myeloid leukemia patients - Wu, Kangni; Feng, Juan; Xiu, Yanghui; Li, Zhifeng; Lin, Zhijuan; Zhao, Haijun; Zeng, Hanyan; Xia, Weilin; Yu, Lian; Xu, Bing (International immunopharmacology, 2020)
Keywords: Acute myeloid leukemia; Adult; Antibodies; Blocking antibodies; Cytokines; Female; Hepatitis A Virus Cellular Receptor 2 - immunology; Humans; Impact prediction; Inflammation; Interferon-gamma - genetics; Interferon-gamma - immunology; Interleukin 2; Intraepithelial Lymphocytes - immunology; Leukemia; Leukemia, Myeloid, Acute - immunology; Lymphocytes; Lymphocytes T; Male; Middle Aged; Myeloid leukemia; PD-1; PD-1 protein; PD-L1 protein; Programmed Cell Death 1 Receptor - immunology; Stem cell transplantation; Stem cells; TIM-3; Transplantation; Tumor Necrosis Factor-alpha - genetics; Tumor Necrosis Factor-alpha - immunology; Tumor necrosis factor-α; Vδ2 T cell; γ-Interferon; Vδ2 T cell; TIM-3; PD-1; Acute myeloid leukemia